Business Wire

CGTN

14.10.2020 16:47:12 CEST | Business Wire | Press release

Share
CGTN: China Vows to Expand All-Around Opening-Up at Shenzhen SEZ's 40th Anniversary

China on Wednesday vowed to unswervingly expand the all-around opening-up of its economy as it held a grand gathering marking the 40th anniversary of the establishment of the Shenzhen Special Economic Zone (SEZ) in this boomtown in southern Guangdong Province.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201014005662/en/

On August 26, 1980, China's national legislature approved the establishment of special economic zones in Shenzhen, Zhuhai and Shantou in Guangdong Province and Xiamen in Fujian Province. Over the past four decades, Shenzhen has been transformed from a small fishing village into a modern metropolis with a permanent population of over 13 million.

Read the article here .

"The world economy is currently facing complicated challenges. By no means should we be stopped by the reversing trends and tides. We should choose the right side of the history to unswervingly expand opening-up in an all-round way, and promote the building of an open world economy and the building of a community with a shared future for mankind," Chinese President Xi Jinping told the gathering.

At a time when the global economic recovery has been complicated by the COVID-19 pandemic and anti-globalization sentiment, China in May this year brought to the table a new development pattern. Known as "dual circulation," it takes the domestic market as the mainstay while letting domestic and foreign markets boost each other.

"The new development pattern is not a closed domestic circulation, but an open domestic and international dual circulation," Xi, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, stressed in the speech.

He pointed out the need to explore a more flexible policy system and a more scientific management system in domestic and international trade, investment and financing, fiscal and tax affairs, financial innovation and border entry and exit.

Shenzhen, a miracle in world development

Shenzhen is a brand-new city created by the CPC and the Chinese people since the country's reform and opening-up and its development over the past 40 years is a miracle in the world development history, Xi said.

From 1980 to 2019, Shenzhen's GDP rose from 270 million yuan to 2.7 trillion yuan ($40 million to $400 billion), with an average annual growth rate of 20.7 percent, according to Xi.

Its fiscal revenue also increased from less than 100 million yuan to 942.4 billion yuan ($14.9 million to $139.8 billion) during the period.

Its total imports and exports climbed from $18 million in 1980 to $431.5 billion in 2019, an average annual growth rate of 26.1 percent, contributing to an all-around opening up, Xi summarized.

People's livelihoods have also greatly improved in Shenzhen, with tremendous advancements in education, medical care, housing and other areas. Its per capita disposable income skyrocketed to 62,500 yuan ($9,272) in 2019, a 31.6-fold growth compared to that of 1985.

Valuable experience

Xi stressed the valuable experience from the development miracles of the special economic zones (SEZs) including Shenzhen.

Below is some of the advice offered by the president:

-- adhere to the concept that development is of paramount importance, insist on the practices of daring to try and daring to be the first, and pursue reform breakthroughs through creative thoughts.

-- remain committed to opening-up on all fronts and continuously enhance the attractiveness of "bringing in" and the competitiveness of "going out."

-- take innovation as the primary driving force and win the upper hand in global technological revolution and industrial transformation.

-- follow the people-centered philosophy of development to allow the people to benefit more from the achievements of reform and development in a fairer way.

-- ensure scientific legislation, strict law enforcement, judicial impartiality and universal law-abiding to make rule of law an important guarantee for the development of the SEZs.

-- carry out the philosophy of "lucid waters and lush mountains are invaluable assets" to achieve sustained development of economy and society as well as ecology and environment in a comprehensive and coordinated way.

-- implement the fundamental principle of "One Country, Two Systems" in a comprehensive and accurate way, and promote the integrated development of the mainland and Hong Kong and Macao.

-- give full play to the leading and exemplary role of the SEZs while making overall plans for the country, so that they can contribute more to national development.

'Engine' for Guangdong-Hong Kong-Macao Greater Bay Area

Hailing Shenzhen as an "engine" for the Guangdong-Hong Kong-Macao Greater Bay Area (GBA)'s development, Xi asked Shenzhen to take active moves to further promote the construction of the area and called for efforts to synergize economic rules and mechanisms in the three regions.

The GBA Initiative was first mentioned in China's 13th Five-Year Plan (2016-2020) and aims to combine the three regions in order to turn it into one of the world's top bay areas and world-class city clusters.

The area encompasses the special administrative regions (SAR) of Hong Kong and Macao, as well as cities of Guangzhou, Shenzhen, Zhuhai, Dongguan, Huizhou, Zhongshan, Foshan, Zhaoqing and Jiangmen in southern China's Guangdong Province.

Local governments need to build regional railroads, allowing talents and goods to flow between the area more efficiently, which will improve market integration, said Xi.

The country will deepen the reform and opening-up of the Qianhai-Shenzhen-Hong Kong pilot cooperation zone and speed up the construction of a comprehensive national science center in the GBA to enhance coordination and cooperation with Hong Kong and Macao.

The GBA's platform should be fully utilized to attract more young talents from Hong Kong and Macao to come to the region to study, work and build a life, providing them with a deeper and wider level of communication and understanding of each other, the president continued.

Xi welcomed greater participation of foreign countries in the reform, opening-up and development of China's special economic zones.

He said foreign participation has been indispensable in building the economic zones over the past 40 years, assisting in the creation of vast development opportunities and offering development benefits for foreign countries.

Shenzhen, the best example for the need of further opening-up: experts

Continuous reform and wider opening-up were key terms in President Xi's speech at the grand gathering, or as some experts pointed out, the southern Chinese city is the best example that shows the need for further opening-up.

"As China's first special economic zone and through the launch of a market-driven scheme that supported the attraction of a large number of foreign investments, the city has become instrumental in making China a prominent player in today's global economy," commented Matteo Giovannini , a Beijing-based finance professional.

The city is home to various leading Chinese tech companies, including telecoms giant Huawei and technology conglomerate Tencent, two of the major companies that the U.S. has been putting pressure on in the most recently souring China-U.S. ties. Some say President Xi's trip "soothes their nerves."

"Xi's visit to Shenzhen and the unveiling of the plan are aimed to encourage the development of the tech industry," Chief Economist for Hang Seng Bank Dan Wang told South China Morning Post.

According to Giovannini, the trip also shines a light at China's continuous determination to open its arms to the international community.

"(His trip) represents an opportunity to emphasize China's uninterrupted commitment to further domestic integration and market opening-up to the rest of the world," he said.

Social Media:

https://www.facebook.com/ChinaGlobalTVNetwork/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye